These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 11070007)
1. Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines. Yoo L; Speck SH J Virol; 2000 Dec; 74(23):11115-20. PubMed ID: 11070007 [TBL] [Abstract][Full Text] [Related]
2. B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1. Yoo LI; Mooney M; Puglielli MT; Speck SH J Virol; 1997 Dec; 71(12):9134-42. PubMed ID: 9371570 [TBL] [Abstract][Full Text] [Related]
3. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells. Schlager S; Speck SH; Woisetschläger M J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690 [TBL] [Abstract][Full Text] [Related]
4. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Puglielli MT; Woisetschlaeger M; Speck SH J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191 [TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformation. Tierney RJ; Nagra J; Rowe M; Bell AI; Rickinson AB J Virol; 2015 Mar; 89(5):2483-93. PubMed ID: 25540367 [TBL] [Abstract][Full Text] [Related]
6. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines. Elliott J; Goodhew EB; Krug LT; Shakhnovsky N; Yoo L; Speck SH J Virol; 2004 Dec; 78(24):14062-5. PubMed ID: 15564516 [TBL] [Abstract][Full Text] [Related]
7. Deletion of Epstein-Barr virus regulatory sequences upstream of the EBNA gene promoter Wp1 is unfavorable for B-Cell immortalization. Yoo LI; Woloszynek J; Templeton S; Speck SH J Virol; 2002 Nov; 76(22):11763-9. PubMed ID: 12388739 [TBL] [Abstract][Full Text] [Related]
8. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. Jin XW; Speck SH J Virol; 1992 May; 66(5):2846-52. PubMed ID: 1313905 [TBL] [Abstract][Full Text] [Related]
9. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Chen A; Zhao B; Kieff E; Aster JC; Wang F J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691 [TBL] [Abstract][Full Text] [Related]
10. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines. Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites. Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268 [TBL] [Abstract][Full Text] [Related]
12. Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection. Yoshioka M; Kikuta H; Ishiguro N; Ma X; Kobayashi K J Gen Virol; 2003 May; 84(Pt 5):1133-1140. PubMed ID: 12692278 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15). Fuentes-Pananá EM; Swaminathan S; Ling PD J Virol; 1999 Jan; 73(1):826-33. PubMed ID: 9847397 [TBL] [Abstract][Full Text] [Related]
14. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice. Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010 [TBL] [Abstract][Full Text] [Related]
15. Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions. Rowe M; Raithatha S; Shannon-Lowe C J Virol; 2014 Oct; 88(20):12065-76. PubMed ID: 25122803 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome. Szymula A; Palermo RD; Bayoumy A; Groves IJ; Ba Abdullah M; Holder B; White RE PLoS Pathog; 2018 Feb; 14(2):e1006890. PubMed ID: 29462212 [TBL] [Abstract][Full Text] [Related]
17. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005 [TBL] [Abstract][Full Text] [Related]
18. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. Woisetschlaeger M; Jin XW; Yandava CN; Furmanski LA; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1991 May; 88(9):3942-6. PubMed ID: 1850841 [TBL] [Abstract][Full Text] [Related]
19. Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells. Paulson EJ; Fingeroth JD; Yates JL; Speck SH Virology; 2002 Jul; 299(1):109-21. PubMed ID: 12167346 [TBL] [Abstract][Full Text] [Related]
20. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]